Abstract
The aim of this study was to assess a physiologically based modeling approach for predicting drug metabolism, tissue distribution, and bioavailability in rat for a structurally diverse set of neutral and moderate-to-strong basic compounds (n = 50). Hepatic blood clearance (CLh) was projected using microsomal data and shown to be well predicted, irrespective of the type of hepatic extraction model (80% within 2-fold). Best predictions of CLh were obtained disregarding both plasma and microsomal protein binding, whereas strong bias was seen using either blood binding only or both plasma and microsomal protein binding. Two mechanistic tissue composition-based equations were evaluated for predicting volume of distribution (Vdss) and tissue-to-plasma partitioning (Ptp). A first approach, which accounted for ionic interactions with acidic phospholipids, resulted in accurate predictions of Vdss (80% within 2-fold). In contrast, a second approach, which disregarded ionic interactions, was a poor predictor of Vdss (60% within 2-fold). The first approach also yielded accurate predictions of Ptp in muscle, heart, and kidney (80% within 3-fold), whereas in lung, liver, and brain, predictions ranged from 47% to 62% within 3-fold. Using the second approach, Ptp prediction accuracy in muscle, heart, and kidney was on average 70% within 3-fold, and ranged from 24% to 54% in all other tissues. Combining all methods for predicting Vdss and CLh resulted in accurate predictions of the in vivo half-life (70% within 2-fold). Oral bioavailability was well predicted using CLh data and Gastroplus Software (80% within 2-fold). These results illustrate that physiologically based prediction tools can provide accurate predictions of rat pharmacokinetics.
Footnotes
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.106.014027.
-
ABBREVIATIONS: PK, pharmacokinetic(s); ADME, absorption, distribution, metabolism, and elimination; AUC, area under the curve; AUMC, area under the first moment curve; CLh, hepatic blood clearance; CLh,plasma, hepatic plasma clearance; CLint, intrinsic clearance; CLoral, oral blood clearance; CLR, renal clearance; CLtot, total blood clearance; E:P, erythrocyte-to-plasma concentration ratio; F, absolute oral bioavailability; FDp, fraction of dose that has reached the portal vein; fum, fraction unbound in microsomes; fup, fraction unbound in plasma; Ht, hematocrit content in blood; PBPK, physiologically based pharmacokinetics; Dvow, vegetable oil:buffer partition coefficient of both the non-ionized and ionized species at pH 7.4; Pow, n-octanol:water partition coefficient of the non-ionized species; Ptp, tissue-to-plasma partition coefficient; Pvow, vegetable oil:water partition coefficient of the non-ionized species; Qh, hepatic blood flow; RB, blood-to-plasma concentration ratio; Sw, aqueous solubility; Vdss, volume of distribution at steady state.
- Received November 22, 2006.
- Accepted January 24, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|